Drug Type Monoclonal antibody |
Synonyms Anti-TCR-alphabeta monoclonal antibody, T10B9 monoclonal antibody, G 022 + [5] |
Target |
Action inhibitors |
Mechanism CD3 inhibitors(T cell surface glycoprotein CD3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft vs Host Disease | Phase 3 | United States | - | - |
Graft vs Host Disease | Phase 3 | - | - | |
Renal transplant rejection | Phase 2 | United States | - | - |
Renal transplant rejection | Phase 2 | - | - | |
Cardiac transplant rejection | Phase 1 | United States | - | - |
Cardiac transplant rejection | Phase 1 | - | - | |
Liver transplant rejection | Clinical | United States | - | - |
Neoplasms | Clinical | United States | - | - |